Coya Therapeutics
COYA
56 hedge funds and large institutions have $32M invested in Coya Therapeutics in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 12 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
3.38% less ownership
Funds ownership: 37.94% → 34.56% (-3.4%)
3% less funds holding
Funds holding: 58 → 56 (-2)
13% less capital inflows, than outflows
Capital inflows: $5.59M | Capital outflows: $6.45M
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prosight Management
Dallas,
Texas
|
+$1.97M |
| 2 |
DME Capital Management
New York
|
+$1.45M |
| 3 |
Private Management Group
Irvine,
California
|
+$415K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$302K |
| 5 |
Prelude Capital Management
New York
|
+$229K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$4.2M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$400K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$231K |
| 4 |
Walleye Capital
New York
|
-$215K |
| 5 |
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$200K |
COYA Hedge Fund Activity: Q1 2026 in Review
56 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2026, worth a combined $32M — down 30% from $46M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of COYA and 9 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 19 added.
The largest buyer was Prosight Management, opening a new position worth an estimated $1.97M. The largest seller was AWM Investment Company, exiting entirely with an estimated $4.2M sold.
- 56 institutional investors held Coya Therapeutics (COYA) as of Q1 2026, down from 58 in Q4 2025.
- Funds reported $32M of Coya Therapeutics stock for Q1 2026, down 30% quarter-over-quarter.
- 9 funds opened new Coya Therapeutics positions in Q1 2026 and 12 closed out, a net change of -3 holders.
- The largest Coya Therapeutics buyer in Q1 2026 was Prosight Management, an estimated $1.97M added.
- The largest Coya Therapeutics seller in Q1 2026 was AWM Investment Company, an estimated $4.2M sold.
Based on aggregated 13F filings for Q1 2026.